- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
PPARG as therapeutic target for antifibrotic therapy ; Vol. 19. 2020, p 227-229
EXCLI journal ; Vol. 19. 2020, p 227-229
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Ghallab, Ahmed
Seddek, Abdellatief
- Handle
-
2003/39762
- URN
-
urn:nbn:de:101:1-2020100903422725355758
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ghallab, Ahmed
- Seddek, Abdellatief
Ähnliche Objekte (12)
Antifibrotic drugs as therapeutic tools in resistant melanoma
Antifibrotic therapy to normalize the tumor microenvironment
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Identification and Modulation of a PPARG-regulated Anti-fibrotic MicroRNA Network in Liver Fibrosis and Hepatocellular Carcinoma
Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy
The downstream PPARγ target LRRC1 participates in early stage adipocytic differentiation
Antifibrotic Therapies in the Liver
The macrophage as therapeutic target
AKT kinases as therapeutic targets
PPARγ [PPAR-gamma] as molecular target of epithelial functions in the gastrointestinal tract
Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment
Antifibrotic drugs as therapeutic tools in resistant melanoma
Antifibrotic therapy to normalize the tumor microenvironment
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Identification and Modulation of a PPARG-regulated Anti-fibrotic MicroRNA Network in Liver Fibrosis and Hepatocellular Carcinoma
Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy
The downstream PPARγ target LRRC1 participates in early stage adipocytic differentiation
Antifibrotic Therapies in the Liver
The macrophage as therapeutic target
AKT kinases as therapeutic targets
PPARγ [PPAR-gamma] as molecular target of epithelial functions in the gastrointestinal tract
Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment
Antifibrotic drugs as therapeutic tools in resistant melanoma
Antifibrotic therapy to normalize the tumor microenvironment
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Identification and Modulation of a PPARG-regulated Anti-fibrotic MicroRNA Network in Liver Fibrosis and Hepatocellular Carcinoma
Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy
The downstream PPARγ target LRRC1 participates in early stage adipocytic differentiation
Antifibrotic Therapies in the Liver
The macrophage as therapeutic target
AKT kinases as therapeutic targets
PPARγ [PPAR-gamma] as molecular target of epithelial functions in the gastrointestinal tract